Table 3. Signature Genes. Normalized Average Expression Level

Total Page:16

File Type:pdf, Size:1020Kb

Table 3. Signature Genes. Normalized Average Expression Level Table 3. Signature genes. Normalized Average Expression Level kmean Function Clone Name Putative Identification FI ES TS3 TS6 Cluster #4 Apoptosis H3035A01 Mouse tumor necrosis factor, alpha-induced protein 2 (Tnfaip2)/ B94 -0.487 0.781 -0.269 -0.28 H3100E04 Mouse inhibitor of apoptosis protein 1 -0.404 0.56 -0.713 -0.117 Cell Cycle H3019C10 Mouse prohibitin (Phb), antiproliferative protein -0.702 0.67 -0.177 -0.162 H3025D07 Mouse Ki-67 -0.115 0.539 -0.592 -0.586 H3116H01 Mouse CDC10 -0.21 0.53 -0.619 -0.539 Transcription/Chromatin H3016B10 Human leucine zipper, down-regulated in cancer 1 (LDOC1) -0.627 0.6 -0.485 0.1 H3036F04 Mouse REX-1 -0.647 0.558 -0.445 -0.264 H3086G02 Mouse DNA methyltransferase 3A (Dnmt3a) -0.669 0.576 -0.328 -0.333 H3105D05 Mouse zinc finger protein 57 (Zfp57) -0.82 0.51 -0.216 -0.138 H3128E07 Mouse cysteine-rich protein 2 CRP2/SmLIM -0.344 0.662 -0.656 -0.111 DNA Replication H3039G12 Mouse 5'-3' exoribonuclease 1 (Xrn1)/Dhm2 -0.192 0.632 -0.575 -0.48 H3064A08 Human replication factor C3 -0.495 0.703 -0.507 -0.04 Energy/Metabolism H3021A12 Mouse tryptophan-tRNA ligase -0.607 0.56 -0.56 -0.058 H3040F06 Mouse Mpv17 transgene, kidney disease mutant (Mpv17), peroxisomal protein -0.453 0.542 -0.699 -0.106 H3043F12 Mouse ferrochelatase (Fech)/ protoheme ferrolyase -0.466 0.514 -0.662 -0.279 H3047F02 Mouse vacuolar-adenosine trisphosphatase -0.596 0.308 -0.734 -0.092 H3075A04 Putative sheep protein-arginine deiminase typeIII -0.022 0.422 -0.906 -0.013 H3090E05 Mouse P450 (cytochrome) oxidoreductase (Por) -0.332 0.564 -0.534 -0.533 H3119G08 Mouse glutathione S-transferase alpha 4 (Gsta4) -0.544 0.477 -0.673 0.146 Heat Shock/Stress H3013D11 Mouse metallothionein II -0.286 0.528 -0.796 0.068 Heat Shock/Stress H3023G01 Mouse heat shock protein 86 kDa 1 (Hsp86-1) -0.659 0.632 -0.076 -0.398 Matrix/Structural Proteins H3015H02 Mouse serine protease inhibitor 6 (Spi6) -0.514 0.66 -0.545 -0.036 H3035B02 Mouse skeletal muscle alpha tropomyosin -0.297 0.676 -0.672 -0.033 H3093F11 Human secretory carrier membrane protein 1 (SCAMP1) -0.414 0.138 -0.884 -0.165 H3097E02 Mouse EH-domain containing protein 2 (Ehd2) -0.355 0.34 -0.869 0.04 H3100F04 Putative human beta-tryptase precursor -0.706 0.527 -0.43 -0.193 H3101B07 Mouse brain neurofilament-L -0.618 0.135 -0.646 -0.426 H3104H03 Putative mouse kinesin-like protein KIF1A -0.763 0.508 -0.37 -0.147 H3116G01 Mouse nuclear pore complex glycoprotein p62 -0.304 0.6 -0.535 -0.509 H3135C02 Mouse galectin-7 keratinocyte lectin -0.34 0.788 -0.411 -0.305 Protein Synthesis/Translational Control H3037E02 Human putative pre-mRNA splicing factor, ATP-dependent RNA helicase -0.329 0.653 -0.402 -0.55 H3073A06 Mouse beta-transducin repeat containing protein/F-box/WD40-repeat protein FWD1 -0.437 0.311 -0.841 0.053 H3135B05 Mouse beta-transducin repeat containing protein/F-box/WD40-repeat protein FWD1 -0.02 0.637 -0.676 -0.367 Signal Transduction H3005F06 Mouse interleukin 1 receptor-associated kinase (Il1rak) -0.187 0.536 -0.803 -0.177 H3035B01 Human putative phosphoprotein C8FW -0.3 0.772 -0.278 -0.484 H3062G12 Mouse large tumor suppressor 1 (Lats1) putative protein kinase -0.407 0.38 -0.817 0.145 H3064C02 Mouse large tumor suppressor 1 (Lats1) putative protein kinase -0.383 0.618 -0.634 -0.26 H3088G02 Human GTP-binding protein (NGB) -0.615 0.527 -0.571 -0.131 H3126B12 Mouse protein kinase inhibitor, gamma (Pkig) -0.674 0.588 -0.437 -0.085 H3136E09 Mouse Rho-associated coiled-coil forming kinase 1 (Rock1) -0.185 0.751 -0.439 -0.455 Unknown H3024C06 Mouse teratocarcinoma expressed serine rich (Tera) -0.453 0.617 -0.614 -0.187 H3041B12 Mouse TI-227 expressed in association with B16 melanoma metastasis -0.457 0.606 -0.649 -0.027 H3049D03 Mouse spinocerebellar ataxia 10 (Sca10) -0.475 0.48 -0.697 -0.237 H3099F09 Mouse pH 34, undifferentiated EC cells specific -0.568 0.175 -0.537 -0.596 H3099F10 Human candidate tumor suppressor gene 21 protein -0.541 0.282 -0.789 -0.059 H3100E06 Human breast carcinoma amplified sequence 1 -0.139 0.529 -0.833 -0.078 H3002A11 Human hypothetical protein -0.362 0.312 -0.867 0.135 H3041C04 Human cDNA clone -0.283 0.605 -0.741 -0.05 H3043G12 Human CGI (comparative gene identification)-73 protein -0.321 0.44 -0.827 -0.131 H3096H06 Human hypothetical protein -0.28 0.559 -0.382 -0.68 H3100H03 Human putative cDNA clone -0.578 0.492 -0.584 -0.285 H3106E06 Human KIAA1100 -0.676 0.671 -0.298 -0.051 H3005E08 -0.5 0.496 -0.643 -0.297 H3009B10 -0.307 0.492 -0.795 -0.176 H3009H01 -0.244 0.574 -0.634 -0.454 H3016C04 -0.567 0.604 -0.435 -0.349 H3016C06 -0.399 0.44 -0.78 -0.194 H3018E07 -0.622 0.57 -0.533 -0.048 H3018G07 -0.633 0.532 -0.373 -0.419 H3022C06 -0.525 0.67 -0.495 -0.169 H3022E11 -0.296 0.659 -0.588 -0.361 H3025F06 -0.553 0.622 -0.502 -0.231 H3025G08 -0.346 0.472 -0.804 -0.092 H3025H06 -0.352 0.495 -0.719 -0.334 H3030C10 -0.504 0.38 -0.766 0.112 H3030E01 -0.496 0.535 -0.632 -0.258 H3032E01 -0.116 0.567 -0.798 -0.163 H3033C09 -0.414 0.505 -0.689 -0.313 H3033E02 -0.402 0.51 -0.759 0 H3034C12 -0.63 0.555 -0.534 -0.087 H3034G03 -0.357 0.539 -0.689 -0.326 H3035A03 -0.31 0.738 -0.579 -0.148 H3036E03 -0.575 0.609 -0.54 -0.07 H3036G02 -0.552 0.397 -0.732 0.003 H3036G03 -0.664 0.479 -0.554 -0.147 H3036G05 -0.482 0.377 -0.786 -0.081 H3036G06 -0.438 0.574 -0.583 -0.368 H3036H04 -0.528 0.434 -0.713 -0.148 H3037C02 -0.249 0.388 -0.882 0.091 H3037C12 -0.273 0.431 -0.855 -0.083 H3038A04 -0.699 0.562 -0.118 -0.424 H3039D11 -0.503 0.472 -0.533 -0.488 H3043E12 -0.283 0.559 -0.749 -0.214 H3043H11 -0.599 0.437 -0.559 -0.368 H3044B04 -0.386 0.542 -0.487 -0.564 H3047G04 -0.206 0.541 -0.692 -0.429 H3048C12 -0.32 0.618 -0.628 -0.344 H3048D12 -0.36 0.515 -0.698 -0.341 H3048E12 -0.255 0.519 -0.779 -0.237 H3049B01 -0.705 0.533 -0.459 -0.081 H3057C12 -0.478 0.593 -0.569 -0.308 H3057E12 -0.378 0.569 -0.671 -0.284 H3057G04 -0.38 0.74 -0.417 -0.365 H3067E12 -0.321 0.548 -0.529 -0.562 H3072E11 -0.314 0.385 -0.848 -0.182 H3075C02 -0.231 0.481 -0.766 -0.357 H3075E02 -0.272 0.361 -0.882 -0.126 H3084B08 -0.446 0.559 -0.328 -0.615 H3088A04 -0.711 0.522 -0.372 -0.287 H3088G03 -0.56 0.67 -0.453 -0.174 H3094E04 -0.583 0.518 -0.623 -0.048 H3094F02 -0.464 0.53 -0.535 -0.464 H3094F05 -0.619 0.143 -0.649 -0.416 H3094G03 -0.696 0.5 -0.472 -0.204 H3095F07 -0.631 0.291 -0.7 -0.161 H3097F04 -0.752 0.507 -0.392 -0.148 H3097G02 -0.765 0.566 -0.19 -0.237 H3097G04 -0.425 0.341 -0.837 -0.027 H3099F07 -0.416 0.475 -0.581 -0.511 H3100A09 -0.252 0.639 -0.699 -0.193 H3100G01 -0.54 0.679 -0.142 -0.474 H3100H05 -0.534 0.524 -0.447 -0.489 H3108C10 -0.465 0.609 -0.401 -0.5 H3116B01 -0.594 0.674 -0.419 -0.128 H3116E03 -0.484 0.628 -0.393 -0.465 H3116G03 -0.342 0.55 -0.629 -0.428 H3117B08 -0.283 0.687 -0.439 -0.503 H3133E08 -0.461 0.574 -0.617 -0.273 H3134G03 -0.629 0.694 -0.142 -0.316 H3134G09 -0.02 0.683 -0.436 -0.584 H3154E11 -0.46 0.521 -0.57 -0.436 H3156C06 -0.529 0.542 -0.647 -0.078 H3157B11 -0.394 0.67 -0.368 -0.509 H3158D03 -0.642 0.45 -0.619 -0.021 Cluster #7 Apoptosis H3029A05 Mouse cellular apoptosis susceptibility protein -0.8 -0.37 0.174 0.437 H3153D07 Mouse p75NTR-associated cell death executor (Nade)/ Bex3 -0.73 -0.531 0.166 0.394 Cell Cycle H3027G03 Mouse cyclin B1 -0.912 -0.159 0.119 0.358 Transcription/Chromatin H3009F04 Mouse GATA-binding protein 2 (Gata2) -0.618 -0.657 0.178 0.39 H3014E10 Mouse transcription factor AP-2, gamma (Tcfap2c) -0.815 -0.467 -0.055 0.337 H3020C07 eHAND -0.639 -0.751 -0.031 0.16 H3027G05 Mouse placentae and embryos oncofetal gene (Pem) -0.931 -0.315 0.122 0.131 H3029A04 Mouse SCIP, myelin-specific POU-domain transcriptional repressor -0.789 -0.507 0.309 0.152 H3076B01 Mouse melanocyte-specific gene 1 (msg1) -0.889 -0.399 0.219 0.026 H3120B02 Mouse placenta specific homeobox 1 (Psx1) -0.839 -0.361 0.402 0.056 H3129D02 Mouse mSin3B -0.685 -0.618 0.373 0.091 H3134A06 Mouse period 3 (Per3), circadian oscillators -0.507 -0.644 0.363 0.441 H3142D02 Mouse upstream transcription factor 1 (Usf1) -0.814 -0.289 0.224 0.449 DNA Replication H3031D01 Mouse Orc1 origin recognition complex 1 -0.78 -0.447 0.436 0.027 H3090G04 Mouse bromodomain-containing FSH-like protein FSRG2 (Fsrg2) -0.484 -0.62 0.121 0.604 H3103E01 Mouse topoisomerase 3 alpha (Top3a) -0.841 -0.346 0.157 0.382 H3108A05 Mouse p53 tumor suppressor -0.699 -0.652 0.179 0.231 H3133D01 Mouse deoxyribonuclease II (Dnase2) -0.524 -0.689 0.345 0.361 Energy/Metabolism H3029A03 Mouse peroxisomal trans 2-enoyl CoA reductase -0.834 -0.453 0.278 0.141 H3032H02 Mouse phosphatidylcholine transfer protein-like (Pctpl) -0.818 -0.502 0.026 0.277 H3040B03 Mouse solute carrier family 9 (sodium/hydrogen exchanger) 3 regulator 1 (Slc9a3r1) -0.863 -0.389 0.092 0.306 H3129D05 Mouse nudix (nucleoside diphosphate linked moiety X)-type motif 5 (Nudt5) -0.765 -0.364 0.241 0.472 H3134D04 Mouse hexokinase -0.555 -0.713 0.048 0.424 H3085D10 Mouse guanine deaminase (Gda) -0.926 -0.35 0.137 -0.017 H3031G08 Putative human monocarbocylate transporter 6 -0.802 -0.414 -0.053 0.425 Matrix/Structural Proteins H3007G06 Mouse endoB cytokeratin -0.813 -0.534 0.189 0.128 H3014H12 Mouse Endo A cytokeratin -0.82 -0.515 0.021 0.246 H3017A12 Mouse synaptogyrin 1 (Syngr1) -0.847 -0.335 0.206 0.355 H3018E05 Mouse Endo A cytokeratin -0.894 -0.401 0.118 0.16 H3027G04 Mouse focal adhesion kinase (Fadk) -0.484 -0.675 0.022 0.555 H3031C01 Mouse EndoA cytokeratin -0.851 -0.464 0.208 0.126 H3031E01 Mouse tissue inhibitor of metalloproteinase 3 (Timp3) -0.783 -0.452 0.275 0.325 H3137A03 Mouse integrin alpha 3A -0.859 -0.332 0.176 0.344 H3137C06 Mouse transglutaminase (TGase) -0.558 -0.768
Recommended publications
  • Supplementary Figure S1 Functional Characterisation of Snmp:GFP
    doi: 10.1038/nature06328 SUPPLEMENTARY INFORMATION SUPPLEMENTARY FIGURE LEGENDS Figure S1 | Functional characterisation of SNMP fusion proteins. Dose-response curve for cVA in Or67d neurons of wild-type (Berlin), SNMP mutant (Or67d- GAL4/+;SNMP1/SNMP2), SNMP:GFP rescue (Or67d-GAL4/UAS- SNMP:GFP;SNMP1/SNMP2) and YFP(1):Or83b/SNMP:YFP(2) rescue (Or67d:GAL4,UAS-YFP(1):Or83b/UAS-SNMP:YFP(2);SNMP1,Or83b2/SNMP2,Or83b1 ) animals. Mean responses are plotted (± s.e.m; wild-type n=47, SNMP mutant n=46, SNMP:GFP rescue n=20; YFP(1):Or83b/SNMP:YFP(2) rescue n=22; ≤4 sensilla/animal, mixed genders). Wild-type and SNMP:GFP rescue responses to cVA are not significantly different (ANOVA; p>0.1175). YFP(1):Or83b/SNMP:YFP(2) rescue responses to cVA are highly significantly different from SNMP mutants and from wild- type (ANOVA; p<0.0001), indicating partial rescue. Figure S2 | Cell type-specific rescue of SNMP expression. a, Immunostaining for mCD8:GFP (anti-GFP, green) and LUSH (magenta) in LUSH-GAL4/UAS-mCD8:GFP animals reveals faithful recapitulation of endogenous expression by the LUSH-GAL4 driver. b, Two-colour RNA in situ hybridisation for SNMP (green) and Or67d (magenta) in antennal sections of wild-type, Or67d neuron SNMP rescue (Or67d-GAL4/UAS- SNMP;SNMP1/SNMP2) and support cell SNMP rescue (LUSH-GAL4/UAS- SNMP;SNMP1/SNMP2) animals. www.nature.com/nature 1 Benton et al., Figure S1 ) -1 wild-type 120 SNMP:GFP rescue 80 YFP(1):Or83b/SNMP:YFP(2) rescue 40 Corrected response (spikes s 0 SNMP-/- 0 0.1 1 10 100 cVA (%) www.nature.com/nature 2 Benton
    [Show full text]
  • Aberrant Expression of Tetraspanin Molecules in B-Cell Chronic Lymphoproliferative Disorders and Its Correlation with Normal B-Cell Maturation
    Leukemia (2005) 19, 1376–1383 & 2005 Nature Publishing Group All rights reserved 0887-6924/05 $30.00 www.nature.com/leu Aberrant expression of tetraspanin molecules in B-cell chronic lymphoproliferative disorders and its correlation with normal B-cell maturation S Barrena1,2, J Almeida1,2, M Yunta1,ALo´pez1,2, N Ferna´ndez-Mosteirı´n3, M Giralt3, M Romero4, L Perdiguer5, M Delgado1, A Orfao1,2 and PA Lazo1 1Instituto de Biologı´a Molecular y Celular del Ca´ncer, Centro de Investigacio´n del Ca´ncer, Consejo Superior de Investigaciones Cientı´ficas-Universidad de Salamanca, Salamanca, Spain; 2Servicio de Citometrı´a, Universidad de Salamanca and Hospital Universitario de Salamanca, Salamanca, Spain; 3Servicio de Hematologı´a, Hospital Universitario Miguel Servet, Zaragoza, Spain; 4Hematologı´a-hemoterapia, Hospital Universitario Rı´o Hortega, Valladolid, Spain; and 5Servicio de Hematologı´a, Hospital de Alcan˜iz, Teruel, Spain Tetraspanin proteins form signaling complexes between them On the cell surface, tetraspanin antigens are present either as and with other membrane proteins and modulate cell adhesion free molecules or through interaction with other proteins.25,26 and migration properties. The surface expression of several tetraspanin antigens (CD9, CD37, CD53, CD63, and CD81), and These interacting proteins include other tetraspanins, integri- F 22,27–30F their interacting proteins (CD19, CD21, and HLA-DR) were ns particularly those with the b1 subunit HLA class II 31–33 34,35 analyzed during normal B-cell maturation and compared to a moleculesFeg HLA DR -, CD19, the T-cell recep- group of 67 B-cell neoplasias. Three patterns of tetraspanin tor36,37 and several other members of the immunoglobulin expression were identified in normal B cells.
    [Show full text]
  • The Tetraspanin TSPAN33 Controls TLR-Triggered Macrophage Activation Through Modulation of NOTCH Signaling
    The Tetraspanin TSPAN33 Controls TLR-Triggered Macrophage Activation through Modulation of NOTCH Signaling This information is current as Almudena Ruiz-García, Susana López-López, José Javier of September 25, 2021. García-Ramírez, Victoriano Baladrón, María José Ruiz-Hidalgo, Laura López-Sanz, Ángela Ballesteros, Jorge Laborda, Eva María Monsalve and María José M. Díaz-Guerra J Immunol published online 29 August 2016 Downloaded from http://www.jimmunol.org/content/early/2016/08/27/jimmun ol.1600421 Supplementary http://www.jimmunol.org/content/suppl/2016/08/27/jimmunol.160042 http://www.jimmunol.org/ Material 1.DCSupplemental Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists by guest on September 25, 2021 • Fast Publication! 4 weeks from acceptance to publication *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2016 by The American Association of Immunologists, Inc. All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. Published August 29, 2016, doi:10.4049/jimmunol.1600421 The Journal of Immunology The Tetraspanin TSPAN33 Controls TLR-Triggered Macrophage Activation through Modulation of NOTCH Signaling Almudena Ruiz-Garcı´a,1 Susana Lo´pez-Lo´pez,1 Jose´ Javier Garcı´a-Ramı´rez, Victoriano Baladro´n, Marı´a Jose´ Ruiz-Hidalgo, Laura Lo´pez-Sanz, A´ ngela Ballesteros, Jorge Laborda, Eva Marı´a Monsalve, and Marı´a Jose´ M.
    [Show full text]
  • Biogenesis of Extracellular Vesicles (EV): Exosomes, Microvesicles, Retrovirus-Like Vesicles, and Apoptotic Bodies
    J Neurooncol (2013) 113:1–11 DOI 10.1007/s11060-013-1084-8 TOPIC REVIEW Biogenesis of extracellular vesicles (EV): exosomes, microvesicles, retrovirus-like vesicles, and apoptotic bodies Johnny C. Akers • David Gonda • Ryan Kim • Bob S. Carter • Clark C. Chen Received: 27 July 2012 / Accepted: 13 February 2013 / Published online: 2 March 2013 Ó Springer Science+Business Media New York 2013 Abstract Recent studies suggest both normal and can- Abbreviations cerous cells secrete vesicles into the extracellular space. Exosomes 30–100 nm secreted vesicles that These extracellular vesicles (EVs) contain materials that originate from the endosomal mirror the genetic and proteomic content of the secreting network cell. The identification of cancer-specific material in EVs Microvesicles 50–2,000 nm vesicles that arise isolated from the biofluids (e.g., serum, cerebrospinal fluid, through direct outward budding urine) of cancer patients suggests EVs as an attractive and fission of the plasma mem- platform for biomarker development. It is important to brane recognize that the EVs derived from clinical samples are Retrovirus-like particles 90–100 nm non-infectious vesicles likely highly heterogeneous in make-up and arose from that resemble retroviral vesicles diverse sets of biologic processes. This article aims to and contain a subset of retroviral review the biologic processes that give rise to various types proteins of EVs, including exosomes, microvesicles, retrovirus like Apoptotic bodies 50–5,000 nm vesicles produced particles, and apoptotic bodies. Clinical pertinence of these from cell undergoing cell death EVs to neuro-oncology will also be discussed. by apoptosis EV Extracellular vesicle Keywords Biomarkers Á Intracellular trafficking Á RLP Retrovirus like particle Membrane budding Á Tetraspanin Á Multi-vesicular bodies ILV Intraluminal vesicle (MVB) Á Tumor microenvironment Á Cancer MVB Multivesicular body TEM Tetraspanin enriched microdo- main ESCRT Endosomal sorting complex required for transport Bob S.
    [Show full text]
  • Influences of Gravitational Intensity on the Transcriptional Landscape of Arabidopsis
    Influences of Gravitational Intensity on the Transcriptional Landscape of Arabidopsis thaliana A dissertation presented to the faculty of the College of Arts and Sciences of Ohio University In partial fulfillment of the requirements for the degree Doctor of Philosophy Alexander D. Meyers May 2020 © 2020 Alexander D. Meyers. All Rights Reserved. 2 This dissertation titled Influences of Gravitational Intensity on the Transcriptional Landscape of Arabidopsis thaliana by ALEXANDER D. MEYERS has been approved for the Department of Molecular and Cellular Biology and the College of Arts and Sciences by Sarah E. Wyatt Professor of Environmental and Plant Biology Florenz Plassmann Dean, College of Arts and Sciences 3 Abstract MEYERS, ALEXANDER D, Ph.D., May 2020, Molecular and Cellular Biology Influences of Gravitational Intensity on the Transcriptional Landscape of Arabidopsis thaliana Director of Dissertation: Sarah E. Wyatt Plants use a myriad of environmental cues to inform their growth and development. The force of gravity has been a consistent abiotic input throughout plant evolution, and plants utilize gravity sensing mechanisms to maintain proper orientation and architecture. Despite thorough study, the specific mechanics behind plant gravity perception remain largely undefined or unproven. At the center of plant gravitropism are dense, specialized organelles called starch statoliths that sediment in the direction of gravity. Herein I describe a series of experiments in Arabidopsis that leveraged RNA sequencing to probe gravity response mechanisms in plants, utilizing reorientation in Earth’s 1g, fractional gravity environments aboard the International Space Station, and simulated fractional and hyper gravity environments within various specialized hardware. Seedlings were examined at organ-level resolution, and the statolith-deficient pgm-1 mutant was subjected to all treatments alongside wildtype seedlings in an effort to resolve the impact of starch statoliths on gravity response.
    [Show full text]
  • Impaired Expression of Tetraspanin 32 (TSPAN32) in Memory T Cells of Patients with Multiple Sclerosis
    brain sciences Article Impaired Expression of Tetraspanin 32 (TSPAN32) in Memory T Cells of Patients with Multiple Sclerosis Maria Sofia Basile 1, Emanuela Mazzon 2 , Katia Mangano 1 , Manuela Pennisi 1, Maria Cristina Petralia 2, Salvo Danilo Lombardo 1 , Ferdinando Nicoletti 1 , Paolo Fagone 1,* and Eugenio Cavalli 2 1 Department of Biomedical and Biotechnological Sciences, University of Catania, Via S. Sofia 89, 95123 Catania, Italy; sofi[email protected] (M.S.B.); [email protected] (K.M.); [email protected] (M.P.); [email protected] (S.D.L.); [email protected] (F.N.) 2 IRCCS Centro Neurolesi “Bonino-Pulejo”, Via Provinciale Palermo, Contrada Casazza, 98124 Messina, Italy; [email protected] (E.M.); [email protected] (M.C.P.); [email protected] (E.C.) * Correspondence: [email protected] Received: 29 November 2019; Accepted: 14 January 2020; Published: 17 January 2020 Abstract: Tetraspanins are a conserved family of proteins involved in a number of biological processes. We have previously shown that Tetraspanin-32 (TSPAN32) is significantly downregulated upon activation of T helper cells via anti-CD3/CD28 stimulation. On the other hand, TSPAN32 is marginally modulated in activated Treg cells. A role for TSPAN32 in controlling the development of autoimmune responses is consistent with our observation that encephalitogenic T cells from myelin oligodendrocyte glycoprotein (MOG)-induced experimental autoimmune encephalomyelitis (EAE) mice exhibit significantly lower levels of TSPAN32 as compared to naïve T cells. In the present study, by making use of ex vivo and in silico analysis, we aimed to better characterize the pathophysiological and diagnostic/prognostic role of TSPAN32 in T cell immunity and in multiple sclerosis (MS).
    [Show full text]
  • Regulation of ADAM10 by the Tspanc8 Family of Tetraspanins and Their Therapeutic Potential
    International Journal of Molecular Sciences Review Regulation of ADAM10 by the TspanC8 Family of Tetraspanins and Their Therapeutic Potential Neale Harrison 1, Chek Ziu Koo 1,2 and Michael G. Tomlinson 1,2,* 1 School of Biosciences, University of Birmingham, Birmingham B15 2TT, UK; [email protected] (N.H.); [email protected] (C.Z.K.) 2 Centre of Membrane Proteins and Receptors (COMPARE), Universities of Birmingham and Nottingham, Midlands, UK * Correspondence: [email protected]; Tel.: +44-(0)121-414-2507 Abstract: The ubiquitously expressed transmembrane protein a disintegrin and metalloproteinase 10 (ADAM10) functions as a “molecular scissor”, by cleaving the extracellular regions from its membrane protein substrates in a process termed ectodomain shedding. ADAM10 is known to have over 100 substrates including Notch, amyloid precursor protein, cadherins, and growth factors, and is important in health and implicated in diseases such as cancer and Alzheimer’s. The tetraspanins are a superfamily of membrane proteins that interact with specific partner proteins to regulate their intracellular trafficking, lateral mobility, and clustering at the cell surface. We and others have shown that ADAM10 interacts with a subgroup of six tetraspanins, termed the TspanC8 subgroup, which are closely related by protein sequence and comprise Tspan5, Tspan10, Tspan14, Tspan15, Tspan17, and Tspan33. Recent evidence suggests that different TspanC8/ADAM10 complexes have distinct substrates and that ADAM10 should not be regarded as a single scissor, but as six different TspanC8/ADAM10 scissor complexes. This review discusses the published evidence for this “six Citation: Harrison, N.; Koo, C.Z.; scissor” hypothesis and the therapeutic potential this offers.
    [Show full text]
  • Supplementary File 1
    Table S1. Immune-related Pattern Recognition Receptors from the transcriptome of two-spotted field crickets No Gene Sequence ID Annotation description 1 TRINITY_DN87689_c0_g8_i1 Apolipophorin 2 TRINITY_DN90320_c4_g2_i2 Apolipophorin-III 3 TRINITY_DN83083_c0_g3_i1 Apolipoprotein D 4 TRINITY_DN87472_c0_g4_i2 Apolipophorin III 1 5 TRINITY_DN79329_c2_g3_i2 ApolipophorinIII 3 isoform B 6 TRINITY_DN87177_c0_g2_i15 Ataxin-7-like protein 1 7 TRINITY_DN69311_c0_g2_i1 Ataxin-2-like protein 8 TRINITY_DN79241_c0_g1_i1 Beta-1,3-glucan-binding protein 9 TRINITY_DN66389_c1_g1_i1 C-type lectin 2 10 TRINITY_DN80953_c0_g1_i1 C-type lectin 13 11 TRINITY_DN62874_c0_g2_i1 Down syndrome cell adhesion molecule-like protein DSCAM2 12 TRINITY_DN87557_c4_g2_i2 Down syndrome cell adhesion molecule-like protein DSCAM2 13 TRINITY_DN88698_c7_g1_i1 Endoplasmic reticulum lectin 1 14 TRINITY_DN81707_c0_g1_i3 Galectin 15 TRINITY_DN89270_c1_g1_i3 Galectin 16 TRINITY_DN87548_c0_g1_i1 GNBP1 17 TRINITY_DN88917_c0_g2_i5 GNBP1 18 TRINITY_DN36711_c0_g1_i1 Hemolymph lipopolysaccharide-binding protein 19 TRINITY_DN89574_c1_g2_i1 Hemolymph lipopolysaccharide-binding protein 20 TRINITY_DN84123_c0_g3_i2 Hemolymph lipopolysaccharide-binding protein 21 TRINITY_DN82224_c1_g1_i1 Hemolymph lipopolysaccharide-binding protein 22 TRINITY_DN74207_c0_g1_i1 Hemolymph lipopolysaccharide-binding protein 23 TRINITY_DN89591_c6_g3_i1 Hemolymph juvenile hormone binding protein 24 TRINITY_DN135327_c0_g1_i1 Hemolymph lipopolysaccharide-binding protein 25 TRINITY_DN84754_c0_g1_i1 Hemolymph juvenile
    [Show full text]
  • Proteomic Comparison Defines Novel Markers to Characterize Heterogeneous Populations of Extracellular Vesicle Subtypes
    Proteomic comparison defines novel markers to characterize heterogeneous populations of extracellular vesicle subtypes Joanna Kowala, Guillaume Arrasb, Marina Colomboa, Mabel Jouvea, Jakob Paul Moratha, Bjarke Primdal-Bengtsona, Florent Dinglib, Damarys Loewb, Mercedes Tkacha, and Clotilde Thérya,1 aInstitut Curie, PSL Research University, INSERM U932, Department “Immunité et Cancer”, 75248 Paris, France; and bInstitut Curie, PSL Research University, Centre de Recherche, Laboratoire de Spectrométrie de masse Protéomique, 75248 Paris, France Edited by Randy Schekman, University of California, Berkeley, CA, and approved January 5, 2016 (received for review October 28, 2015) Extracellular vesicles (EVs) have become the focus of rising interest or recovered by high-speed ultracentrifugation (8), in the ab- because of their numerous functions in physiology and pathology. sence of demonstration of their intracellular origin. Such iso- Cells release heterogeneous vesicles of different sizes and intra- lation procedures coisolate mixed EV populations, which we will cellular origins, including small EVs formed inside endosomal call “small EVs” (sEVs), for lack of better term, in the rest of this compartments (i.e., exosomes) and EVs of various sizes budding article. Because EVs of different intracellular origins probably from the plasma membrane. Specific markers for the analysis and have different functional properties (9, 10), the mixed nature of isolation of different EV populations are missing, imposing EV preparations has made the growing literature increasingly important limitations to understanding EV functions. Here, EVs confusing, with contradictory proposed functions and clinical uses from human dendritic cells were first separated by their sedimen- of vesicles being regularly published. The lack of specific purifi- tation speed, and then either by their behavior upon upward cation and characterization tools prevents a clear understanding of floatation into iodixanol gradients or by immuno-isolation.
    [Show full text]
  • Role of Palmitoylation
    FEBS 25943 FEBS Letters 516 (2002) 139^144 View metadata, citation and similar papers at core.ac.uk brought to you by CORE Di¡erential stability of tetraspanin/tetraspanin interactions:provided by Elsevier - Publisher Connector role of palmitoylation Ste¤phanie Charrina, Serge Manie¤b, Michael Oualida, Martine Billarda, Claude Boucheixa, Eric Rubinsteina;Ã aINSERM U268, Ho“pital Paul Brousse, 94807 Villejuif Cedex, France bLaboratoire de Ge¤ne¤tique UMR 5641, Faculte¤ de Me¤decine, 8 avenue Rockefeller, Lyon, France Received 7 January 2002; revised 22 February 2002; accepted 22 February 2002 First published online 7 March 2002 Edited by Felix Wieland The mechanisms that support these pleiotropic functional Abstract The tetraspanins associate with various surface molecules and with each other to build a network of molecular observations are not understood. However, a striking prop- interactions, the tetraspanin web. The interaction of tetraspanins erty of tetraspanins is their presence in molecular complexes with each other seems to be central for the assembly of the organized in di¡erent levels. Primary complexes contain one tetraspanin web. All tetraspanins studied, CD9, CD37, CD53, tetraspanin linked to a speci¢c molecular partner. They com- CD63, CD81, CD82 and CD151, were found to incorporate bine through tetraspanin/tetraspanin interactions to form [3H]palmitate. By site-directed mutagenesis, CD9 was found to higher-order complexes that are collectively called the tetra- be palmitoylated at any of the four internal juxtamembrane spanin web [1,2]. Several of the primary complexes have been regions. The palmitoylation of CD9 did not influence the identi¢ed, for example (tetraspanin/partner) CD81/CD19, partition in detergent-resistant membranes but contributed to CD81/integrin K4L1, CD151/K3L1, CD151/K6L1, CD9 or the interaction with CD81 and CD53.
    [Show full text]
  • Electronic Supplementary Information S9
    Electronic Supplementary Material (ESI) for Metallomics. This journal is © The Royal Society of Chemistry 2019 Electronic Supplementary Information S9 . Changes in gene expression due to As III exposure in the contrasting hairy roots. HYBRIDIZATION 1: LIST OF UP-REGULATED GENES Fold Change Probe Set ID ([0.1.HR] vs [0.HR]) Blast2GO description Genbank Accessions Serine/threonine -protein phosphatase 7 long form BT2M444_at 101.525 homolog AJ538927 DV159578_at 67.016 Retrotransposon Tnt1 s231d long terminal repeat DV159578 EB427540_at 49.6314 DNA repair metallo-beta-lactamase family protein EB427540 C3356_at 39.8605 Late embryogenesis abundant domain-containing protein DV157779 C7375_at 39.0452 wall-associated serine threonine kinase BP525596 C11724_at 37.103 5' exonuclease Apollo-like, transcript variant 2 AJ718369 EB682553_at 36.7071 EIF4A-2 EB682553 U92011_at 34.5134 apocytochrome b U92011 C5842_at 33.8783 heat shock protein 90 EB432766 AF211619_at 31.8765 AF211619 BC1M4448_s_at 31.2217 AJ538430 TT39_L17_at 29.7963 lysine-ketoglutarate reductase EB429701_at 29.3945 EB429701 BP137485_at 29.0749 Retrotransposon Tnt1 s231d long terminal repeat BP137485 CV021716_at 28.8452 Plastocyanin-like domain-containing protein CV021716 DW002835_at 27.8539 peroxidase DW002835 EB429725_at 27.6171 Carbonic anhydrase, transcript variant 1 (ca1), mRNA EB429725 TT19_B11_at 26.3284 50s ribosomal protein l16 DV158314_at 24.4108 DV158314 C7180_at 23.668 cytochrome oxidase subunit i BP528067 EB445091_at 22.6679 lysine-ketoglutarate reductase EB445091 GC227C_at
    [Show full text]
  • Engagement of CD81 Induces Ezrin Tyrosine Phosphorylation and Its Cellular Redistribution with Filamentous Actin
    Research Article 3137 Engagement of CD81 induces ezrin tyrosine phosphorylation and its cellular redistribution with filamentous actin Greg P. Coffey1, Ranjani Rajapaksa1, Raymond Liu1, Orr Sharpe2, Chiung-Chi Kuo1, Sharon Wald Krauss3, Yael Sagi1, R. Eric Davis4, Louis M. Staudt4, Jeff P. Sharman1, William H. Robinson2 and Shoshana Levy1,* 1Stanford University, School of Medicine, Division of Oncology, Stanford, CA 94305, USA 2Stanford University, School of Medicine, Division of Immunology and Rheumatology, GRECC Veterans Affairs, Palo Alto Health Care System, Palo Alto, CA 94304, USA 3Life Sciences Division, University of California Lawrence Berkeley National Laboratory, Berkeley, CA 94720, USA 4Metabolism Branch, National Cancer Institute, Bethesda, MD 20892, USA *Author for correspondence ([email protected]) Accepted 10 June 2009 Journal of Cell Science 122, 3137-3144 Published by The Company of Biologists 2009 doi:10.1242/jcs.045658 Summary CD81 is a tetraspanin family member involved in diverse this association was disrupted when Syk activation was blocked. cellular interactions in the immune and nervous systems and Taken together, these studies suggest a model in which CD81 in cell fusion events. However, the mechanism of action of CD81 interfaces between the plasma membrane and the cytoskeleton and of other tetraspanins has not been defined. We reasoned by activating Syk, mobilizing ezrin, and recruiting F-actin to that identifying signaling molecules downstream of CD81 would facilitate cytoskeletal reorganization and cell signaling. This provide mechanistic clues. We engaged CD81 on the surface mechanism might explain the pleiotropic effects induced in of B-lymphocytes and identified the induced tyrosine- response to stimulation of cells by anti-CD81 antibodies or by phosphorylated proteins by mass spectrometry.
    [Show full text]